Renaissance Capital logo

ICVX News

CAVA soars 99% in one of the best first days for a larger IPO in the past two years

CAVA

Restaurant chain CAVA Group (CAVA) soared 99% in its debut on Thursday, delivering one of the best first-day performances for a $100+ million IPO in the past two years. ...read more

US IPO Weekly Recap: Biotechs pop and Robinhood flops in a record 20 IPO week

ICVX

The 2021 US IPO market continues to break records. 20 IPOs went public this past week, the most in a single week since the year 2000. New filers have slowed ahead of the August lull, with just one IPO submitting an initial filing. Three issuers postponed, citing either volatility or market conditions: vehicle battery maker Clarios International (BTRY), specialty...read more

Vaccine biotech Icosavax prices upsized IPO at $15 midpoint

ICVX

Icosavax, a Phase 1 biotech developing vaccines for respiratory diseases, raised $182 million by offering 12.1 million shares at $15, within the range of $14 to $16. The company offered 2.1 million more shares than anticipated. Icosavax is developing its virus-like particle, or VLP, platform technology to develop vaccines against infectious diseases, with an initial focus on life...read more

US IPO Week Ahead: Robinhood’s billion-dollar deal headlines a 25 IPO week

HOOD

Updated Monday, 7/26. After another week of record activity, the IPO market is expected to remain hot with 25 IPOs scheduled for the week ahead. If all scheduled IPOs begin trading as expected, it would be the busiest week for the US IPO market in more than two decades. Long-awaited retail brokerage Robinhood Markets (HOOD) plans to raise $2.2...read more